237 related articles for article (PubMed ID: 12006763)
1. HLA-G in melanoma: A new strategy to escape from immunosurveillance?
Ugurel S; Reinhold U; Tilgen W
Onkologie; 2002 Apr; 25(2):129-34. PubMed ID: 12006763
[TBL] [Abstract][Full Text] [Related]
2. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
3. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.
Rouas-Freiss N; Bruel S; Menier C; Marcou C; Moreau P; Carosella ED
Int J Cancer; 2005 Oct; 117(1):114-22. PubMed ID: 15880415
[TBL] [Abstract][Full Text] [Related]
4. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.
Paul P; Rouas-Freiss N; Khalil-Daher I; Moreau P; Riteau B; Le Gal FA; Avril MF; Dausset J; Guillet JG; Carosella ED
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4510-5. PubMed ID: 9539768
[TBL] [Abstract][Full Text] [Related]
5. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
Menier C; Riteau B; Carosella ED; Rouas-Freiss N
Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
[TBL] [Abstract][Full Text] [Related]
6. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
[TBL] [Abstract][Full Text] [Related]
7. HLA-G expression in human melanoma cells: protection from NK cytolysis.
Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
[TBL] [Abstract][Full Text] [Related]
8. HLA-G in skin cancer: a wolf in sheep's clothing?
Urosevic M; Dummer R
Hum Immunol; 2003 Nov; 64(11):1073-80. PubMed ID: 14602238
[TBL] [Abstract][Full Text] [Related]
9. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Algarra I; García-Lora A; Cabrera T; Ruiz-Cabello F; Garrido F
Cancer Immunol Immunother; 2004 Oct; 53(10):904-10. PubMed ID: 15069585
[TBL] [Abstract][Full Text] [Related]
10. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
Yie SM; Hu Z
Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
[TBL] [Abstract][Full Text] [Related]
12. [HLA-G: a tolerance molecule implicated in the escape of tumors from immunosurveillance].
Paul P; Rouas-Freiss N; Carosella ED
Pathol Biol (Paris); 1999 Oct; 47(8):766-70. PubMed ID: 10573693
[TBL] [Abstract][Full Text] [Related]
13. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.
Lesport E; Baudhuin J; LeMaoult J; Sousa S; Doliger C; Carosella ED; Favier B
Hum Immunol; 2009 Dec; 70(12):1000-5. PubMed ID: 19654030
[TBL] [Abstract][Full Text] [Related]
14. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
[TBL] [Abstract][Full Text] [Related]
16. HLA-G promotes immune tolerance.
Rouas-Freiss N; Paul P; Dausset J; Carosella ED
J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
[TBL] [Abstract][Full Text] [Related]
17. [Role of MHC class I molecules in anti-tumoral mechanisms in human malignant melanoma].
Dissemond J; Grabbe S
Hautarzt; 2006 Aug; 57(8):690-6. PubMed ID: 16163561
[TBL] [Abstract][Full Text] [Related]
18. Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
Fonsatti E; Nicolay HJ; Sigalotti L; Calabrò L; Pezzani L; Colizzi F; Altomonte M; Guidoboni M; Marincola FM; Maio M
Clin Cancer Res; 2007 Jun; 13(11):3333-8. PubMed ID: 17545540
[TBL] [Abstract][Full Text] [Related]
19. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
20. Expression of HLA G in human tumors is not a frequent event.
Real LM; Cabrera T; Collado A; Jimenez P; Garcia A; Ruiz-Cabello F; Garrido F
Int J Cancer; 1999 May; 81(4):512-8. PubMed ID: 10225437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
